Showing 2081-2090 of 3315 results for "".
- Blanchard Contact Lenses Launches Onefit Spotlight Programhttps://modernod.com/news/blanchard-contact-lenses-launches-onefit-spotlight-program/2477769/Blanchard Contact Lenses has announced the launch of their new Onefit Spotlight program, which was designed to highlight the great work of those who are fitting the Onefit family of scleral lenses. Prac
- 1-800 Contacts Launches Online Glasses Lens Replacement Brand, Boomerang Lenseshttps://modernod.com/news/covid-19-weekly-review/2477734/1-800 Contacts unveiled Boomerang, an online lens replacement service that provides new lenses for consumers to put in their current glasses without having to visit an eye doctor or optical shop. As the current health crisis began to unfold, and eyecare providers and optical shops began f
- UK Surpasses Italy In Recorded Coronavirus Deaths, Now Leads Europe In Fatalitieshttps://modernod.com/news/uk-surpasses-italy-in-recorded-coronavirus-deaths-now-leads-europe-in-fatalities/2477715/Over 32,000 people have died from the new coronavirus in the United Kingdom, according to the Office for National Statistics, marking the first time in the pandemic that it has led Europe in the number of deaths, according to an NPR
- World Leaders Pledge $8 Billion To Fight COVID-19; US Skips Meetinghttps://modernod.com/news/world-leaders-pledge-8-billion-to-fight-covid-19-us-skips-meeting/2477711/A global alliance responded to calls to fight the coronavirus pandemic on Monday, as world leaders pledged some $8 billion to develop vaccines and treatments to fight COVID-19, according to an NPR
- Mojo Vision Raises Additional $51 Million to Develop Smart Contact Lenshttps://modernod.com/news/mojo-vision-raises-additional-51-million-to-develop-smart-contact-lens/2477678/Mojo Vision announced it has raised more than $51 million in a Series B-1 investment round to propel the development of its smart contact lens, Mojo Lens. This new round brings Mojo Vision’s total funding to date to more than $159 million. In January, Mojo announced that it is in th
- European Leaders, WHO Team Up on $8 Billion Pandemic Vaccine Responsehttps://modernod.com/news/european-leaders-who-team-up-on-8b-pandemic-vaccine-response/2477664/The leaders of Germany and France and a host of other EU countries and groups have come together with the World Health Organization (WHO) for an $8 billion push for a new vaccine against COVID-19, according to a FierceBiotech
- Leo Lens Pharma Appoints Dan Myers CEOhttps://modernod.com/news/leo-lens-pharma-appoints-dan-myers-ceo/2477589/Leo Lens Pharma has announced the appointment of Dan Myers as Chief Executive Officer. Prior to joining Leo Lens, Mr. Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors. Before founding Alimera, Mr. Myers was
- New Peer-Reviewed Paper Offers Advice to Contact Lens Practitioners During COVID-19 Pandemichttps://modernod.com/news/new-peer-reviewed-paper-offers-advice-to-contact-lens-practitioners-during-covid-19-pandemic/2477569/A new peer-reviewed paper from five prominent ocular scientists aims to help eye care practitioners (ECPs) instruct and reassure contact lens wearers during the global COVID-19 pandemic. Published in Contact Lens & Anterior Eye,
- Contact Lens Institute Shares New CDC Guidance for Contact Lens Wear and COVID-19https://modernod.com/news/contact-lens-institute-shares-new-cdc-guidance-for-contact-lens-wear-and-covid-19/2477563/The Contact Lens Institute is sharing new guidance issued this week by the U.S. Centers for Disease Control and Prevention (CDC) regarding contact lens wear and care amid the COVID-19 pandemic. The direction,
- Pfizer Aims to Start Clinical Testing of Lead Compound Against SARS-CoV-2 in Third Quarterhttps://modernod.com/news/pfizer-aims-to-start-clinical-testing-of-lead-compound-against-sars-cov-2-in-third-quarter/2477560/In an update on its efforts to combat COVID-19, Pfizer said results of initial screening assays have led it to zero in on a lead protease inhibitor with antiviral activity against SARS-CoV-2 based on preliminary data. The company stated that it will now perform preclinical testing on the compound